Thermo Fisher Scientific Inc. (NYSE:TMO) agreed to acquire The Binding Site Group Ltd. from Nordic Capital and Five Arrows Managers SAS for $2.3 billion on October 31, 2022. Upon completion, The Binding Site Group will become part of the Specialty Diagnostics segment. The transaction, which is expected to be completed in the first half of 2023, is subject to customary closing conditions, including regulatory approvals.

Transaction is expected to be accretive to adjusted earnings per share.